Physician profile
Alexander D Tapper
NPI 1205215621
$9,662.40
in general payments reported to CMS, 2019-2025
45 companies · $2,886 in 2025
The $2,886 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,314 · 2020: $1,073 · 2021: $432 · 2022: $798 · 2023: $1,356 · 2024: $1,802 · 2025: $2,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,077 · Travel and Lodging: $827 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,076.87 |
| Travel and Lodging | $827.40 |
| Education | $139.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,322.45 | 2019-2023 | Spaceoar Vue System - 10ml |
| Histosonics, INC. | $1,052.40 | 2025 | |
| Intuitive Surgical, INC. | $900.00 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $765.67 | 2021-2025 | Lynparza |
| Astellas Pharma US INC | $734.39 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $485.03 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $427.53 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $307.53 | 2021-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $278.74 | 2023-2025 | Provenge |
| Olympus America INC. | $261.18 | 2019-2025 | Itind System |
| Merck Sharp & Dohme LLC | $249.22 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Abbvie INC. | $223.81 | 2022-2025 | Botox |
| Antares Pharma, INC. | $197.79 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $197.79 | 2022-2025 | Jelmyto |
| Procept Biorobotics Corporation | $172.17 | 2022-2025 | Aquabeam System |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $147.30 | 2025 | |
| Siemens Medical Solutions USA, INC. | $136.90 | 2024 | |
| Teleflex LLC | $136.50 | 2023 | Urolift |
| Laborie Medical Technologies Corp. | $125.70 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $124.81 | 2021-2023 | Xiaflex |
| Axonics, INC. | $115.10 | 2021-2024 | Bulkamid, Axonics |
| Ferring Pharmaceuticals INC. | $98.18 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $94.23 | 2021-2025 | |
| Photocure INC | $93.96 | 2023-2025 | Cysview |
| Coloplast Corp | $92.16 | 2023-2024 | Speedicath |
| 180 Medical, INC. | $91.16 | 2023-2024 | |
| Halozyme INC | $85.69 | 2023 | |
| Verity Pharmaceuticals INC. | $80.34 | 2024-2025 | Tlando |
| Smith+Nephew, INC. | $78.42 | 2023-2024 | Stravix, Grafix Pl, Grafix |
| Allergan, INC. | $64.17 | 2021-2022 | |
| Endo USA, INC. | $60.85 | 2025 | Xiaflex |
| Sun Pharmaceutical Industries INC. | $58.19 | 2024 | |
| Tolmar, INC. | $56.15 | 2023-2025 | Eligard, Jatenzo |
| Immunitybio, INC. | $43.91 | 2025 | |
| Blue Earth Diagnostics | $43.40 | 2021-2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $37.13 | 2025 | |
| Srs Medical Systems, INC. | $36.56 | 2020 | |
| Integra Lifesciences Corporation | $32.54 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Clarus Therapeutics INC. | $30.66 | 2021 | |
| Tempus Ai, INC | $27.54 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.23 | 2025 | Oxlumo |
| Amgen INC. | $19.86 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $19.28 | 2022 | |
| Genzyme Corporation | $17.93 | 2021 | |
| Medtronic, INC. | $17.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Tapper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.